1. Home
  2. ARL vs TRDA Comparison

ARL vs TRDA Comparison

Compare ARL & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARL
  • TRDA
  • Stock Information
  • Founded
  • ARL 1999
  • TRDA 2016
  • Country
  • ARL United States
  • TRDA United States
  • Employees
  • ARL N/A
  • TRDA N/A
  • Industry
  • ARL Building operators
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARL Real Estate
  • TRDA Health Care
  • Exchange
  • ARL Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • ARL 262.8M
  • TRDA 233.5M
  • IPO Year
  • ARL N/A
  • TRDA 2021
  • Fundamental
  • Price
  • ARL $16.16
  • TRDA $5.59
  • Analyst Decision
  • ARL
  • TRDA Strong Buy
  • Analyst Count
  • ARL 0
  • TRDA 3
  • Target Price
  • ARL N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • ARL 1.7K
  • TRDA 215.2K
  • Earning Date
  • ARL 11-06-2025
  • TRDA 11-04-2025
  • Dividend Yield
  • ARL N/A
  • TRDA N/A
  • EPS Growth
  • ARL N/A
  • TRDA N/A
  • EPS
  • ARL N/A
  • TRDA N/A
  • Revenue
  • ARL $48,139,000.00
  • TRDA $79,476,000.00
  • Revenue This Year
  • ARL N/A
  • TRDA N/A
  • Revenue Next Year
  • ARL N/A
  • TRDA N/A
  • P/E Ratio
  • ARL N/A
  • TRDA N/A
  • Revenue Growth
  • ARL N/A
  • TRDA N/A
  • 52 Week Low
  • ARL $9.43
  • TRDA $4.93
  • 52 Week High
  • ARL $18.28
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • ARL 58.72
  • TRDA 50.40
  • Support Level
  • ARL $15.96
  • TRDA $5.08
  • Resistance Level
  • ARL $17.00
  • TRDA $5.51
  • Average True Range (ATR)
  • ARL 0.26
  • TRDA 0.28
  • MACD
  • ARL -0.02
  • TRDA 0.03
  • Stochastic Oscillator
  • ARL 55.32
  • TRDA 67.16

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: